Live
FierceBiotechChina’s Oricell raises $110M for carcinoma CAR-T plans ahead of IPO pushFierceBiotech'Can it actually deliver?': Why Big Pharma is making the leap to the quantum realmEndpoints NewsNovo's double departures: As GLP-1 luminary retires, an obesity leader goes to Boehringer IngelheimBioPharma DiveWomen have awaited a revolution in menopause. It hasn’t arrived.Endpoints NewsChina-based CAR-T company Oricell raises $40M more as it looks to go publicIlluminaIllumina Stock: Competitive Threats Priced In (NASDAQ:ILMN) - Seeking AlphaRoche MediaCall for Applications: Roche Health Journalism Award 2026 - fundsforNGOsFierceBiotechChutes & Ladders—Former TreeFrog CEO leaps to Orano MedThermo FisherSeer, Thermo Fisher bring deep mass spec proteomics to 10,000-sample Singapore biobank study - R&D WorldThermo FisherThermo Fisher Partnership With PRECISE Puts Proteomics At Core Of TMO Story - simplywall.stFierceBiotechPhilips recalls Trilogy Evo ventilator software, warns of ‘under-delivery’ of therapyeLifeTranslational control in the spinal cord regulates gene expression and pain hypersensitivity in the chronic phase of neuropathic pain
eLife Apr 10, 2026

Translational control in the spinal cord regulates gene expression and pain hypersensitivity in the chronic phase of neuropathic pain

Translational control in the spinal cord regulates gene expression and pain hypersensitivity in the chronic phase of neuropathic pain

Original
Body unavailable. Use the original source.

Directory

59 All